Pharmacoeconomic and clinical implications of sequential therapy for metastatic renal cell carcinoma patients in Central and Eastern Europe
Introduction: The incidence and mortality rates of kidney cancer in the Central and Eastern European (CEE) region are among the highest in the world. Access to second and subsequent lines of metastatic renal cell carcinoma (mRCC) therapies is highly varied in the region. Despite the increasing body...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2016
|
| Sorozat: | EXPERT OPINION ON PHARMACOTHERAPY
17 No. 1 |
| doi: | 10.1517/14656566.2016.1107043 |
| mtmt: | 2978013 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/16830 |